The Journal “suPAR News” No. 2, 2019 is out – read it here!

Thu Dec 12 2019

Read the Journal “suPAR News” No. 2, 2019 – with lots of interesting articles and interviews from around Europe!

Read the Journal here:

pdfsuPAR News No. 2, 2019

Among others, read the articles

  • “suPAR in Chronic and Acute Heart Failure”by MD, PhD Anne Marie Dupuy, University Hospital of Montpellier, France – which is the first hospital where suPAR is in clinical routine on cobas c502 from Roche Diagnostics.
  • “suPAR predicts complications in type 1 diabetes”, with interviews with Prof. Peter Rossing and Dr. Viktor Rotbain Curovic, Steno Diabetes Center in Denmark, about suPAR´s predictive qulities for complications in type 1 diabetes.
  • “suPAR may guide antibiotic treatment of patients suspected of developing sepsis” by Prof. Evangelos J. Giamarellos-Bourboulis, MD, PhD from the Attikon University Hospital in Greece, where he is heading a study about suPAR in sepsis patients.
  • “suPAR measured before and after major non-cardiac surgery may predict the risk of future complications and mortality” by Asst. Prof. Athanasios Chalkias, University Hospital of Larisa, Greece, about his prospective , single-center observational study, aiming to investigate if suPAR measured pre-operatively and immediately after surgery, can predict the risk of future complications and post-operative mortality following major non-cardiac surgery.

Read these articles and many more in the second issue of suPAR News here: 
pdfsuPAR News No. 2, 2019

+800

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates